A study lead by researchers from Mayo Clinic suggests remission from Crohn’s disease may be more likely if patients receive biologic therapy combined with immune-suppressing drugs first instead of ...

Stelara is a biologic medicine used to treat moderate to severe Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that cause inflammation ...

Specific protein signatures can predict Crohn's disease and ulcerative colitis, enabling early intervention in IBD. The study identified 34 proteins for Crohn's disease and 45 for ulcerative colitis, ...

ROCHESTER — A team of universities and biotech companies, headed by Mayo Clinic researchers in Rochester and Arizona, recently earned a $42.8 million federal award to produce a "living pharmacy" ...

Ulcerative colitis and Crohn’s disease are types of inflammatory bowel disease (IBD) that cause irritation and inflammation in the gastrointestinal tract (GI tract). The immune system attacks the GI ...

Inflammatory bowel disease (IBD) is a complex, lifelong condition that includes Crohn’s disease and ulcerative colitis. One of the most common questions patients ask me is, “Which medication is right ...

Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. I think the most important thing when you ...

An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...

As mentioned, Crohn’s colitis is a subtype of Crohn’s disease that only affects the colon. “We typically label Crohn’s based on what part of the gastrointestinal tract it affects,” says Sara ...